GSK Future Growth
Future criteria checks 3/6
GSK is forecast to grow earnings and revenue by 8.9% and 3.3% per annum respectively. EPS is expected to grow by 9.2% per annum. Return on equity is forecast to be 43% in 3 years.
Key information
8.9%
Earnings growth rate
9.2%
EPS growth rate
Pharmaceuticals earnings growth | 14.4% |
Revenue growth rate | 3.3% |
Future return on equity | 43.0% |
Analyst coverage | Good |
Last updated | n/a |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2024 | 33,110 | 5,532 | 6,260 | 8,798 | 18 |
12/31/2023 | 31,869 | 5,301 | 5,316 | 7,765 | 20 |
12/31/2022 | 31,023 | 4,645 | 5,739 | 7,455 | 19 |
3/31/2022 | 36,476 | 5,114 | 7,438 | 10,163 | N/A |
12/31/2021 | 34,114 | 4,385 | 5,793 | 7,952 | N/A |
9/30/2021 | 33,326 | 4,313 | 6,003 | 8,040 | N/A |
6/30/2021 | 32,895 | 4,389 | 4,834 | 6,339 | N/A |
3/31/2021 | 32,427 | 5,257 | 7,028 | 7,807 | N/A |
12/31/2020 | 34,099 | 5,749 | 7,457 | 8,441 | N/A |
9/30/2020 | 34,259 | 6,371 | 6,833 | 8,039 | N/A |
6/30/2020 | 34,998 | 6,679 | 8,751 | 9,693 | N/A |
3/31/2020 | 35,183 | 5,380 | 6,628 | 8,322 | N/A |
12/31/2019 | 33,754 | 4,645 | 6,261 | 8,020 | N/A |
9/30/2019 | 33,052 | 4,561 | 6,832 | 8,686 | N/A |
6/30/2019 | 31,759 | 4,427 | 6,488 | 8,248 | N/A |
3/31/2019 | 31,260 | 3,904 | 6,735 | 8,221 | N/A |
12/31/2018 | 30,821 | 3,623 | 6,881 | 8,421 | N/A |
9/30/2018 | 30,263 | 1,862 | 5,521 | 7,171 | N/A |
6/30/2018 | 30,014 | 1,656 | 5,140 | 6,991 | N/A |
3/31/2018 | 30,024 | 1,035 | 4,549 | 6,637 | N/A |
12/31/2017 | 30,186 | 1,532 | 4,764 | 6,918 | N/A |
9/30/2017 | 30,133 | 2,335 | 4,776 | 7,040 | N/A |
6/30/2017 | 29,832 | 1,931 | 4,865 | 6,910 | N/A |
3/31/2017 | 29,044 | 1,676 | 5,272 | 7,138 | N/A |
12/31/2016 | 27,889 | 912 | 4,428 | 6,497 | N/A |
9/30/2016 | 26,589 | 301 | 3,260 | 5,007 | N/A |
6/30/2016 | 25,174 | 31 | 1,802 | 3,721 | N/A |
3/31/2016 | 24,530 | 615 | 783 | 2,702 | N/A |
12/31/2015 | 23,923 | 8,422 | N/A | 2,569 | N/A |
9/30/2015 | 23,823 | 9,809 | N/A | 3,278 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 001102657's forecast earnings growth (8.9% per year) is above the savings rate (-0.2%).
Earnings vs Market: 001102657's earnings (8.9% per year) are forecast to grow faster than the Swiss market (7.5% per year).
High Growth Earnings: 001102657's earnings are forecast to grow, but not significantly.
Revenue vs Market: 001102657's revenue (3.3% per year) is forecast to grow slower than the Swiss market (3.9% per year).
High Growth Revenue: 001102657's revenue (3.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 001102657's Return on Equity is forecast to be very high in 3 years time (43%).